Search | IOVS | ARVO Journals

Showing 1 – 20 of 42

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Fluorescence Imaging of Biofilm on Eyelashes

Michael Bahren Choi; Donna B Stolz; Eric D Donnenfeld; Henry D Perry

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):831. doi:

ARVO Annual Meeting Abstract July 2019

Differential bacterial colonization and biofilm formation on punctal occluders in vitro.

Lola Grillo; Michael Hadjiargyrou; Eric D Donnenfeld; Henry D Perry

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4170. doi:

ARVO Annual Meeting Abstract June 2015

A One-year, Multicenter, Randomized, Double-masked Placebo-controlled Study of Lifitegrast Ophthalmic Solution 5.0% in Patients with Dry Eye: Findings for Subjects Electing to Use Artificial Tears

Kelly K Nichols; Parag A Majmudar; Eric D Donnenfeld; Aparna Raychadhuri; Charles P Semba

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):325. doi:

ARVO Annual Meeting Abstract June 2015

Retrospective Assessment of the Routine Use of Loteprednol Etabonate Gel 0.5% Following LASIK and PRK Surgery

Clifford Salinger; Michael Gordon; Mitchell Jackson; Eric D Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3932. doi:

ARVO Annual Meeting Abstract June 2013

A Single 700 μg Dexamethasone Intravitreal Implant (Ozurdex) Effectively Treats Complex Post-Operative Cystoid Macular Edema

Daniel Kiernan; Glenn Stoller; Ken Carnevale; Nina Mondoc; Eric Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3274. doi:

ARVO Annual Meeting Abstract March 2012

Astigmatism Correction Post Penetrating Keratoplasty (PK) Using a Femtosecond Laser System (LensX)

Nicholas Nissirios; Henry D. Perry; Eric Donnenfeld; Erfan Nadji

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1503. doi:

ARVO Annual Meeting Abstract April 2011

Real Time Intraoperative Wavefront Aberrometry To Refine Outcomes In Patients With Long Or Short Axial Lengths Undergoing Cataract Surgery

Allon Barsam; Henry D. Perry; Eric D. Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5699. doi:

ARVO Annual Meeting Abstract April 2011

An Investigation of the Safety and Efficacy Of Subconjunctival Bevacizumab in the Treatment of Corneal Neovascularization

Nicholas Nissirios; Renee Solomon; Allon Barsam; Jay Fiore; Zac Davis; Alicia Perry; Marcelle Morcos; Eric D. Donnenfeld; Henry D. Perry

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6384. doi:

ARVO Annual Meeting Abstract April 2011

Xalatan® (latanoprost) is Better Tolerated than Travatan Z® (travoprost) in Ocular Hypertensive or Glaucoma Patients with Mild to Moderate Dry Eye

Marguerite B. McDonald; Stanley J. Berke; Eric D. Donnenfeld; Russell Fumuso; Ronald M. Caronia; Gerard D'Aversa; Henry D. Perry; Paul R. Galstian; Raymond E. Mariani; Richard T. Sturm

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3840. doi:

ARVO Annual Meeting Abstract April 2010

Preservation of Corneal Innervation With Femtosecond Laser Inverted Sidecut Flaps

E. Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2855. doi:

ARVO Annual Meeting Abstract April 2010

An Investigation of New, Real-Time, Intraoperative Aberrometry to Evaluate and Improve Accuracy in IOL Power Selection in Eyes Undergoing Cataract Surgery Following Previous Refractive Surgery

R. Solomon; E. Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4565. doi:

ARVO Annual Meeting Abstract April 2010

Incidence of Concomitant Cataract and Dry Eye: A Prospective Health Assessment of Cataract Patients’ Ocular Surface

W. Trattler; E. Donnenfeld; P. Majmudar; J. Vukich; D. Goldberg; G. Berdy; P. Karpecki; M. Packer; C. Reilly; K. Stonecipher

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5411. doi:

ARVO Annual Meeting Abstract April 2010

An Anterior Chamber Toxicity Study Evaluating Besivance, Azasite and Ciprofloxacin

P. J. Ness; N. Mamalis; L. Werner; S. Maddula; D. K. Davis; E. Donnenfeld; R. J. Olson

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6420. doi:

ARVO Annual Meeting Abstract April 2009

Prospective Investigation of Intravitreal Injection Needles Cultured Immediately Following Injection of Corticosteroids, AvastinR or Lucentis R

H. D. Perry; G. S. Stoller; K. B. Carnevale; S. McCormick; M. Shah; S. A. Berger; E. D. Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5021. doi:

ARVO Annual Meeting Abstract April 2009

Effects of Xalatan® (Latanoprost Ophthalmic Solution) or Travatan Z® (Travoprost Ophthalmic Solution) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients: An Exploratory Study

M. B. McDonald; E. D. Donnenfeld; H. D. Perry; G. D'Aversa; M. A. Swerdin; D. M. Sachs; J. R. Wittpenn, Jr.; J. K. Oats; R. E. Mariani; P. R. Galstian

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4652. doi:

ARVO Annual Meeting Abstract April 2009

Scanning Electron Microscopy Ultrastructural Comparison of 150 kHz Femtosecond Laser Versus Microkeratome LASIK Corneal Flap Creation

R. Solomon; E. Donnenfeld; H. Perry

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):558. doi:

ARVO Annual Meeting Abstract May 2008

Topical Loteprednol 0.5% Induction Therapy Improves Topical Cyclosporine Emulsion Tolerability in Chronic Dry Eye Disease

J. D. Sheppard, Jr.; E. D. Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):99. doi:

ARVO Annual Meeting Abstract May 2008

Argon Laser Iridoplasty to Improve Visual Function Following Multifocal IOL Implantation

R. Solomon; E. D. Donnenfeld; H. D. Perry; J. Stein; J. Holladay

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1035. doi:

ARVO Annual Meeting Abstract May 2007

Anesthesia and Ocular Tolerability of Topical Non-Steroidal Anti-Inflammatory Drugs: A Direct Comparison Between Ketorolac and Bromfenac

T. Y. Chou; H. D. Perry; P. J. G. Maris, Jr.; E. D. Donnenfeld; M. Su

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4269. doi:

ARVO Annual Meeting Abstract May 2007

The Effect of Decreasing Cyclosporine 0.05% on Dry Eye Disease After One Year of Therapy

M. Y. Su; H. D. Perry; E. D. Donnenfeld; J. R. Wittpenn

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):374. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Fluorescence Imaging of Biofilm on Eyelashes

Differential bacterial colonization and biofilm formation on punctal occluders in vitro.

A One-year, Multicenter, Randomized, Double-masked Placebo-controlled Study of Lifitegrast Ophthalmic Solution 5.0% in Patients with Dry Eye: Findings for Subjects Electing to Use Artificial Tears

Retrospective Assessment of the Routine Use of Loteprednol Etabonate Gel 0.5% Following LASIK and PRK Surgery

A Single 700 μg Dexamethasone Intravitreal Implant (Ozurdex) Effectively Treats Complex Post-Operative Cystoid Macular Edema

Astigmatism Correction Post Penetrating Keratoplasty (PK) Using a Femtosecond Laser System (LensX)

Real Time Intraoperative Wavefront Aberrometry To Refine Outcomes In Patients With Long Or Short Axial Lengths Undergoing Cataract Surgery

An Investigation of the Safety and Efficacy Of Subconjunctival Bevacizumab in the Treatment of Corneal Neovascularization

Xalatan® (latanoprost) is Better Tolerated than Travatan Z® (travoprost) in Ocular Hypertensive or Glaucoma Patients with Mild to Moderate Dry Eye

Preservation of Corneal Innervation With Femtosecond Laser Inverted Sidecut Flaps

An Investigation of New, Real-Time, Intraoperative Aberrometry to Evaluate and Improve Accuracy in IOL Power Selection in Eyes Undergoing Cataract Surgery Following Previous Refractive Surgery

Incidence of Concomitant Cataract and Dry Eye: A Prospective Health Assessment of Cataract Patients’ Ocular Surface

An Anterior Chamber Toxicity Study Evaluating Besivance, Azasite and Ciprofloxacin

Prospective Investigation of Intravitreal Injection Needles Cultured Immediately Following Injection of Corticosteroids, AvastinR or Lucentis R

Effects of Xalatan® (Latanoprost Ophthalmic Solution) or Travatan Z® (Travoprost Ophthalmic Solution) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients: An Exploratory Study

Scanning Electron Microscopy Ultrastructural Comparison of 150 kHz Femtosecond Laser Versus Microkeratome LASIK Corneal Flap Creation

Topical Loteprednol 0.5% Induction Therapy Improves Topical Cyclosporine Emulsion Tolerability in Chronic Dry Eye Disease

Argon Laser Iridoplasty to Improve Visual Function Following Multifocal IOL Implantation

Anesthesia and Ocular Tolerability of Topical Non-Steroidal Anti-Inflammatory Drugs: A Direct Comparison Between Ketorolac and Bromfenac

The Effect of Decreasing Cyclosporine 0.05% on Dry Eye Disease After One Year of Therapy

To View More...

You must be signed into an individual account to use this feature.